Total Payments
$8,786
2024 Payments
$500.49
Companies
60
Transactions
454
Medicare Patients
1,226
Medicare Billing
$143,442
Payment Breakdown by Category
Food & Beverage$8,686 (98.9%)
Other$99.43 (1.1%)
Education$0.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,686 | 447 | 98.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $99.43 | 6 | 1.1% |
| Education | $0.42 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,173 | 50 | $0 (2024) |
| Eisai Inc. | $699.86 | 24 | $0 (2024) |
| Biogen, Inc. | $625.03 | 30 | $0 (2024) |
| GENZYME CORPORATION | $475.05 | 28 | $0 (2023) |
| UCB, Inc. | $438.23 | 35 | $0 (2023) |
| US WorldMeds, LLC | $385.80 | 19 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $295.20 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $291.22 | 13 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $281.66 | 16 | $0 (2024) |
| Neurelis, Inc. | $244.59 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $500.49 | 23 | ABBVIE INC. ($146.19) |
| 2023 | $872.03 | 41 | AbbVie Inc. ($416.52) |
| 2022 | $1,623 | 89 | ABBVIE INC. ($289.29) |
| 2021 | $1,514 | 88 | AbbVie Inc. ($266.46) |
| 2020 | $704.49 | 42 | GENZYME CORPORATION ($102.78) |
| 2019 | $1,132 | 60 | Biogen, Inc. ($198.16) |
| 2018 | $2,115 | 95 | Eisai Inc. ($501.06) |
| 2017 | $324.18 | 16 | Purdue Pharma L.P. ($95.64) |
All Payment Transactions
454 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 12/05/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 11/05/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Neurology | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.27 | General |
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Neurology | ||||||
| 09/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/03/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Neurology | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/25/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $30.59 | General |
| Category: Neurology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.61 | General |
| 06/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $24.11 | General |
| Category: Neuroscience | ||||||
| 04/18/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Neurology | ||||||
| 04/04/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Neurology | ||||||
| 03/27/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Neurology | ||||||
| 01/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Neurology | ||||||
| 12/21/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $17.69 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 198 | 259 | $49,933 | $31,230 |
| 2022 | 17 | 424 | 511 | $67,891 | $44,450 |
| 2021 | 7 | 217 | 294 | $51,946 | $35,562 |
| 2020 | 17 | 387 | 459 | $49,176 | $32,200 |
Total Patients
1,226
Total Services
1,523
Medicare Billing
$143,442
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 40 | 92 | $13,800 | $8,400 | 60.9% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 24 | 24 | $8,400 | $6,217 | 74.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 30 | 31 | $9,300 | $4,969 | 53.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 46 | $5,520 | $3,716 | 67.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 33 | $4,718 | $3,494 | 74.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 22 | 22 | $6,600 | $3,273 | 49.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,595 | $1,161 | 72.8% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 36 | 36 | $12,600 | $9,522 | 75.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 39 | 84 | $12,600 | $8,161 | 64.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 100 | $11,000 | $7,941 | 72.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 34 | 35 | $10,500 | $6,038 | 57.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 34 | 34 | $10,200 | $5,208 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $4,495 | $3,181 | 70.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 28 | $3,976 | $2,883 | 72.5% |
| 82306 | Vitamin d-3 level | Office | 2022 | 15 | 15 | $750.00 | $437.48 | 58.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 17 | 17 | $425.00 | $224.69 | 52.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 17 | 17 | $340.00 | $177.18 | 52.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 14 | 14 | $210.00 | $134.20 | 63.9% |
| 83735 | Magnesium level | Office | 2022 | 16 | 16 | $160.00 | $105.74 | 66.1% |
| 83540 | Iron level | Office | 2022 | 16 | 16 | $142.08 | $102.12 | 71.9% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2022 | 17 | 17 | $119.00 | $101.36 | 85.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2022 | 17 | 17 | $136.00 | $86.96 | 63.9% |
| 82540 | Creatine measurement | Office | 2022 | 17 | 17 | $170.00 | $77.86 | 45.8% |
| 82248 | Bilirubin level, direct | Office | 2022 | 17 | 17 | $68.00 | $67.12 | 98.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 92 | $10,120 | $7,274 | 71.9% |
About Dr. Anthonette Sparman, M.D
Dr. Anthonette Sparman, M.D is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1598027682.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthonette Sparman, M.D has received a total of $8,786 in payments from pharmaceutical and medical device companies, with $500.49 received in 2024. These payments were reported across 454 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($8,686).
As a Medicare-enrolled provider, Sparman has provided services to 1,226 Medicare beneficiaries, totaling 1,523 services with total Medicare billing of $143,442. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Brooklyn, NY
- Active Since 06/13/2012
- Last Updated 04/25/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1598027682
Products in Payments
- Fycompa (Drug) $657.73
- QULIPTA (Drug) $634.19
- UBRELVY (Drug) $433.90
- ACTHAR (Biological) $413.88
- AUBAGIO (Drug) $343.44
- ZEPOSIA (Drug) $301.44
- Briviact (Drug) $296.35
- Morphabond ER (Drug) $291.22
- VALTOCO (Drug) $244.59
- SYMPROIC (Drug) $238.26
- TYSABRI (Biological) $224.97
- Xadago (Drug) $211.17
- TEGSEDI (Drug) $204.72
- MOVANTIK (Drug) $197.53
- EMGALITY (Drug) $179.80
- GOCOVRI (Drug) $179.60
- TECFIDERA (Drug) $173.35
- HETLIOZ (Drug) $162.07
- INBRIJA (Drug) $157.39
- LYRICA (Drug) $145.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680